Showing results (1241-1250 of 1,385) with videos related to

Sort By:
Pageof 139
The Journal of Pathology|November 5, 2021
Deep learning identifies inflamed fat as a risk factor for lymph node metastasis in early colorectal cancerScarlet Brockmoeller, Amelie Echle, Narmin Ghaffari Laleh, et al.
Nature|June 17, 2011
A conditional knockout resource for the genome-wide study of mouse gene functionWilliam C Skarnes, Barry Rosen, Anthony P West, et al.
The Journal of Experimental Medicine|August 12, 2025
Design and characterization of HIV-1 vaccine candidates to elicit antibodies targeting multiple epitopesHarry B Gristick, Harald Hartweger, Yoshiaki Nishimura, et al.
The Lancet. Healthy Longevity|November 20, 2022
Quality-of-life outcomes in older patients with early-stage rectal cancer receiving organ-preserving treatment with hypofractionated short-course radiotherapy followed by transanal endoscopic microsurgery (TREC): non-randomised registry of patients unsuitable for total mesorectal excisionAlexandra Gilbert, Victoria Homer, Kristian Brock, et al.
Journal of Animal Science|July 13, 2012
Performance by spring and fall-calving cows grazing with full, limited, or no access to toxic Neotyphodium coenophialum-infected tall fescueJ D Caldwell, K P Coffey, J A Jennings, et al.
Scientific Reports|September 19, 2024
The ATOM-Seq sequence capture panel can accurately predict microsatellite instability status in formalin-fixed tumour samples, alongside routine gene mutation testingKanishta Srihar, Arief Gusnanto, Susan D Richman, et al.
Environmental Research|July 18, 2015
Arsenic exposure and hepatitis E virus infection during pregnancyChristopher D Heaney, Brittany Kmush, Ana Navas-Acien, et al.
Pediatric Radiology|September 24, 2013
Pediatric nephrogenic systemic fibrosis is rarely reported: a RADAR reportBeatrice Nardone, Elise Saddleton, Anne E Laumann, et al.
Trials|August 31, 2017
A rectal cancer feasibility study with an embedded phase III trial design assessing magnetic resonance tumour regression grade (mrTRG) as a novel biomarker to stratify management by good and poor response to chemoradiotherapy (TRIGGER): study protocol for a randomised controlled trialNick J Battersby, Mit Dattani, Sheela Rao, et al.
Global Change Biology|October 13, 2025
Demystifying the Romanticized Narratives About Carbon Credits From Voluntary Forest ConservationThales A P West, Kelsey Alford-Jones, Philippe Delacote, et al.
Pageof 139